SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN)
RGEN 149.37-4.5%Jan 30 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harvey Allen who wrote (388)1/8/2008 10:32:59 AM
From: Bob Laz  Read Replies (1) of 395
 
Very interesting Harvey.
My preference would be to see a purchase of IP / patents or a company that does not enjoy our "brain" power so we could grow and expand their intellectual property.
My concern is always dilution and the time it takes to profit via expansion or expand and grow new IP. Having said that maybe the positive URIDINE P2 was a growth stimulus - and with that large growth possibility well worth it - their brains can make that judgement call.
And again the reason I prefer a buyout is that we do not have to wait for development - wonder if it will be successful - go through choppy waters - wonder if the Q meets the streets expectations - etc. A bird in the hand is worth 2 in the bush.
BIG PROFIT RIGHT NOW! thats what would be a real blessing.
Love the possibilities and from what I have read Walter is conservative when spending OUR MONEY.
Last - I did get a legal opinion from a very experienced patent attorney prior to taking my large position - he said "RGEN will prevail in both cases - the first will be pretty small - the second will be significant" and what I really really like is the BMY patent is not based on contingency so we retain much more of the profit / settlement (no % to attorneys).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News